Acitretin mitigates uroporphyrin-induced bone defects in congenital erythropoietic porphyria models is a research paper published in Scientific Reports (2021). On theSindex it has a DataRank of 0.333. It has been cited 5 times, with 4 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.269
From this paper's citation signal
Citation Network Contribution
0.0640
From 3 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 4 citers.
National Institutes of Health
Grant: DK116548
National Institutes of Health
Grant: HL150784
National Institutes of Health
Grant: P30DK020572
NIDDK NIH HHS
Grant: R01 DK116548
NHLBI NIH HHS
Grant: R35 HL150784
National Institutes of Health
Grant: 5R01DK116548-02
Mechanism of Proteotoxicity and Experimental Therapeutic Approaches in Porphyria
National Institutes of Health
Grant: 5R35HL150784-02
Genetic and therapeutic studies of hemostatic and thrombotic disorders using zebrafish
National Institutes of Health
Grant: 5P30DK020572-37
ADMINISTRATIVE CORE
FWCI
0.22
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals